| Hansel_2008 |
Prospective cohort |
2001-2003 |
6 months |
2-6 |
100 |
USA |
NA |
20.0 |
both |
gas_stove_gas_heat_total_dose_response |
0.83 |
0.72 |
Wheeze, cough, or chest tightness day |
aIRR |
PM2.5, distance from curb, type of street in front of home, season of sampling, age, sex, race of child, ETS, mother's education level; showed minimal correlation between ambient NO2 and indoor NO2 |
1.02 |
0.98 |
1.06 |
| Hansel_2008 |
Prospective cohort |
2001-2003 |
6 months |
2-6 |
100 |
USA |
NA |
20.0 |
both |
gas_stove_gas_heat_total_dose_response |
0.83 |
0.72 |
Wheeze, cough, or chest tightness with slow activity |
aIRR |
PM2.5, distance from curb, type of street in front of home, season of sampling, age, sex, race of child, ETS, mother's education level; showed minimal correlation between ambient NO2 and indoor NO2 |
1.04 |
0.97 |
1.07 |
| Hansel_2008 |
Prospective cohort |
2001-2003 |
6 months |
2-6 |
100 |
USA |
NA |
20.0 |
both |
gas_stove_gas_heat_total_dose_response |
0.83 |
0.72 |
Wheeze, or limited speech |
aIRR |
PM2.5, distance from curb, type of street in front of home, season of sampling, age, sex, race of child, ETS, mother's education level; showed minimal correlation between ambient NO2 and indoor NO2 |
1.08 |
1.04 |
1.13 |
| Hansel_2008 |
Prospective cohort |
2001-2003 |
6 months |
2-6 |
100 |
USA |
NA |
20.0 |
both |
gas_stove_gas_heat_total_dose_response |
0.83 |
0.72 |
Wheeze, cough, chest tightness with running |
aIRR |
PM2.5, distance from curb, type of street in front of home, season of sampling, age, sex, race of child, ETS, mother's education level; showed minimal correlation between ambient NO2 and indoor NO2 |
1.04 |
1.00 |
1.08 |
| Hansel_2008 |
Prospective cohort |
2001-2003 |
6 months |
2-6 |
100 |
USA |
NA |
20.0 |
both |
gas_stove_gas_heat_total_dose_response |
0.83 |
0.72 |
Cough without cold |
aIRR |
PM2.5, distance from curb, type of street in front of home, season of sampling, age, sex, race of child, ETS, mother's education level; showed minimal correlation between ambient NO2 and indoor NO2 |
1.07 |
1.03 |
1.11 |
| Hansel_2008 |
Prospective cohort |
2001-2003 |
6 months |
2-6 |
100 |
USA |
NA |
20.0 |
both |
gas_stove_gas_heat_total_dose_response |
0.83 |
0.72 |
Wheeze, cough, or chest tightness with waking |
aIRR |
PM2.5, distance from curb, type of street in front of home, season of sampling, age, sex, race of child, ETS, mother's education level; showed minimal correlation between ambient NO2 and indoor NO2 |
1.06 |
1.02 |
1.09 |
| Esplugues_2011 |
Prospective cohort |
2003-2005 |
1.0 |
0-1 |
NA |
Spain |
NA |
NA |
both |
gas_stove_dose_response |
NA |
NA |
Lower respiratory tract infection |
aOR |
sex, smoking at week 12 of pregnancy, going to a day-care center, zone of residence, season of birth |
1.04 |
0.69 |
1.57 |
| Esplugues_2011 |
Prospective cohort |
2003-2005 |
1.0 |
0-1 |
NA |
Spain |
NA |
NA |
both |
gas_stove_dose_response |
NA |
NA |
Bronchiolitis |
aOR |
sex, smoking at week 12 of pregnancy, number of person who live together, zone of residence, season of birth) |
1.12 |
0.72 |
1.71 |
| Esplugues_2011 |
Prospective cohort |
2003-2005 |
1.0 |
0-1 |
NA |
Spain |
NA |
NA |
both |
gas_stove_dose_response |
NA |
NA |
Bronchitis |
aOR |
sex, smoking at week 12 of pregnancy, going to a day-care center, zone of residence, season of birth |
0.75 |
0.39 |
1.46 |
| Esplugues_2011 |
Prospective cohort |
2003-2005 |
1.0 |
0-1 |
NA |
Spain |
NA |
NA |
both |
gas_stove_dose_response |
NA |
NA |
Wheezing |
aOR |
sex, smoking at week 12 of pregnancy, number of persons who live together, going to a day-care center, zone of residence, season of birth) |
1.14 |
0.75 |
1.71 |
| Esplugues_2011 |
Prospective cohort |
2003-2005 |
1.0 |
0-1 |
NA |
Spain |
NA |
NA |
both |
gas_stove_dose_response |
NA |
NA |
Persistent cough |
aOR |
zone of residence, season of birth |
1.74 |
0.93 |
3.22 |
| Belanger_2013 |
Prospective cohort |
2006-2009 |
4 months |
5-10 |
100 |
USA |
NA |
5.0 |
stove |
gas_stove_total_dose_response |
NA |
NA |
Asthma symptom score |
aOR |
each 5 ppb increase beyond 6 ppb, adj for age, sex, general atopy, season, sensitization and exposure to five indoor allergens, mother's education, ETS, maintenance medication use (maintenance med use was associated with SES variables: mother's ed, ETS, ethnicity) |
1.88 |
1.02 |
3.57 |
| Belanger_2013 |
Prospective cohort |
2006-2009 |
4 months |
5-10 |
100 |
USA |
NA |
5.0 |
stove |
gas_stove_total_dose_response |
NA |
NA |
Wheeze |
aOR |
each 5 ppb increase beyond 6 ppb, adj for age, sex, general atopy, season, sensitization and exposure to five indoor allergens, mother's education, ETS, maintenance medication use (maintenance med use was associated with SES variables: mother's ed, ETS, ethnicity) |
2.22 |
1.19 |
4.12 |
| Belanger_2013 |
Prospective cohort |
2006-2009 |
4 months |
5-10 |
100 |
USA |
NA |
5.0 |
stove |
gas_stove_total_dose_response |
NA |
NA |
Asthma symptoms night |
aOR |
each 5 ppb increase beyond 6 ppb, adj for age, sex, general atopy, season, sensitization and exposure to five indoor allergens, mother's education, ETS, maintenance medication use (maintenance med use was associated with SES variables: mother's ed, ETS, ethnicity) |
2.31 |
1.35 |
4.00 |
| Belanger_2013 |
Prospective cohort |
2006-2009 |
4 months |
5-10 |
100 |
USA |
NA |
5.0 |
stove |
gas_stove_total_dose_response |
NA |
NA |
Reliever use |
aOR |
each 5 ppb increase beyond 6 ppb, adj for age, sex, general atopy, season, sensitization and exposure to five indoor allergens, mother's education, ETS, maintenance medication use (maintenance med use was associated with SES variables: mother's ed, ETS, ethnicity) |
3.17 |
1.77 |
5.66 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bronchopulm displasia |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Systemic steroid use |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.34 |
0.86 |
2.07 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bronchopulm displasia |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Wheeze or cough |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.21 |
0.76 |
1.92 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bronchopulm displasia |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Reliever use |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.02 |
0.65 |
1.61 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bronchopulm displasia |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Limited activity |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.18 |
0.74 |
1.88 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bronchopulm displasia |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Respiratory symptoms night |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.64 |
0.93 |
2.89 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bpd on resp support |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Systemic steroid use |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.44 |
0.71 |
2.95 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bpd on resp support |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Wheeze or cough |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
1.39 |
0.66 |
2.94 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bpd on resp support |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Reliever use |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
0.85 |
0.43 |
1.69 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bpd on resp support |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Limited activity |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
0.97 |
0.44 |
2.11 |
| Rice_2020 |
Cross-sectional |
2016-2018 |
2 months |
0-16 |
NA |
USA |
Bpd on resp support |
NA |
both |
gas_stove_or_heat_combustion_vs_electric |
0.5 |
0.43 |
Respiratory symptoms night |
aOR |
clustered by subject and adjusted for race/ethnicity, insurance status, age at time of environmental assessment, age at time of resp outcomes qx completion |
2.24 |
0.60 |
8.45 |
| Dai_2021 |
Prospective cohort |
2002-2012 |
9-11 years |
42-54 |
16 |
Australia |
NA |
NA |
both |
gas_stove_heat_vs_electric |
0.1 |
0.28 |
Asthma prevalent |
aOR |
adjusted for age, sex, atopy, nitrogen dioxide and occupation at the sixth decade |
2.64 |
1.22 |
5.70 |